妊娠41周以上口服米索前列醇与阴道米索前列醇的Bishop评分变化及分娩事件的差异

Maskasoni Maskasoni, J. Dewantiningrum
{"title":"妊娠41周以上口服米索前列醇与阴道米索前列醇的Bishop评分变化及分娩事件的差异","authors":"Maskasoni Maskasoni, J. Dewantiningrum","doi":"10.20473/mog.v31i22023.61-67","DOIUrl":null,"url":null,"abstract":"HIGHLIGHTS\n\nOral misoprostol is more effective than vaginal misoprostol in cervical ripening as a part of induction of labor.\nOral misoprostol is as safe as vaginal misoprostol.\n\n \nABSTRACT\nObjective: To compare Bishop score changes and labor event between oral and vaginal misoprostol in pregnancy beyond 41 weeks.\nMaterials and Methods: A total of 52 pregnant women with more than 41 weeks of gestation, had a Bishop score less than 5, and were undergoing induction labor were randomly divided into two groups: oral and vaginal misoprostol. In the oral misoprostol group, participants were given 25 mg of misoprostol in a solution with a concentration of 1 ug/ml every 2 hours. In the vaginal misoprostol group, a 25 mg misoprostol tablet was inserted into the posterior fornix every 6 hours. The two groups were compared in terms of Bishop score during the first 6 hours, changes in Bishop score, labor at term events, neonatal outcomes, complications, and side effects after the administration of misoprostol.\nResults: The oral group showed significantly higher changes in Bishop score compared to the vaginal group (5.5 vs 3.6; p=0.0001). The median interval times for induction of labor at term, induction at stage II, and induction at birth were found to be shorter in the oral misoprostol group compared to the vaginal group (7.3 hours vs 10.6 hours, 14.0 hours vs 16.8 hours, and 14.6 hours vs 17.6 hours; p=0.002, 0.003, 0.002). Labor at term occurred much more frequently in the oral group (53.8% vs 15.4%). Additionally, the oral misoprostol group had a 3.5 times higher likelihood of experiencing labor at term within the first 6 hours after the initial administration compared to the vaginal group (OR 3.5, 95% CI 1.33-9.23).\nConclusion: Oral administration of misoprostol for cervical ripening has been demonstrated to be more effective than vaginal administration, greater bishop score changes while maintaining an equivalent level of safety.","PeriodicalId":52893,"journal":{"name":"Majalah Obstetri dan Ginekologi","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The difference of Bishop score change and labor event between oral and vaginal misoprostol in pregnancy beyond 41 weeks\",\"authors\":\"Maskasoni Maskasoni, J. Dewantiningrum\",\"doi\":\"10.20473/mog.v31i22023.61-67\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"HIGHLIGHTS\\n\\nOral misoprostol is more effective than vaginal misoprostol in cervical ripening as a part of induction of labor.\\nOral misoprostol is as safe as vaginal misoprostol.\\n\\n \\nABSTRACT\\nObjective: To compare Bishop score changes and labor event between oral and vaginal misoprostol in pregnancy beyond 41 weeks.\\nMaterials and Methods: A total of 52 pregnant women with more than 41 weeks of gestation, had a Bishop score less than 5, and were undergoing induction labor were randomly divided into two groups: oral and vaginal misoprostol. In the oral misoprostol group, participants were given 25 mg of misoprostol in a solution with a concentration of 1 ug/ml every 2 hours. In the vaginal misoprostol group, a 25 mg misoprostol tablet was inserted into the posterior fornix every 6 hours. The two groups were compared in terms of Bishop score during the first 6 hours, changes in Bishop score, labor at term events, neonatal outcomes, complications, and side effects after the administration of misoprostol.\\nResults: The oral group showed significantly higher changes in Bishop score compared to the vaginal group (5.5 vs 3.6; p=0.0001). The median interval times for induction of labor at term, induction at stage II, and induction at birth were found to be shorter in the oral misoprostol group compared to the vaginal group (7.3 hours vs 10.6 hours, 14.0 hours vs 16.8 hours, and 14.6 hours vs 17.6 hours; p=0.002, 0.003, 0.002). Labor at term occurred much more frequently in the oral group (53.8% vs 15.4%). Additionally, the oral misoprostol group had a 3.5 times higher likelihood of experiencing labor at term within the first 6 hours after the initial administration compared to the vaginal group (OR 3.5, 95% CI 1.33-9.23).\\nConclusion: Oral administration of misoprostol for cervical ripening has been demonstrated to be more effective than vaginal administration, greater bishop score changes while maintaining an equivalent level of safety.\",\"PeriodicalId\":52893,\"journal\":{\"name\":\"Majalah Obstetri dan Ginekologi\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-08-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Majalah Obstetri dan Ginekologi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20473/mog.v31i22023.61-67\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Majalah Obstetri dan Ginekologi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20473/mog.v31i22023.61-67","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

作为引产的一部分,口服米索前列醇比阴道米索前列醇在宫颈成熟中更有效。口服米索前列醇和阴道使用米索前列醇一样安全。目的:比较妊娠41周以上口服和阴道米索前列醇的Bishop评分变化和产程事件。材料与方法:选取52例妊娠41周以上、Bishop评分小于5分的引产孕妇,随机分为口服和阴道米索前列醇两组。在口服米索前列醇组,每2小时给予25毫克米索前列醇溶液,浓度为1微克/毫升。阴道使用米索前列醇组,每6小时将米索前列醇片25 mg插入后穹窿。比较两组在使用米索前列醇后前6小时的Bishop评分、Bishop评分变化、足月分娩事件、新生儿结局、并发症和副作用。结果:口服组Bishop评分变化明显高于阴道组(5.5 vs 3.6;p = 0.0001)。与阴道组相比,口服米索前列醇组足月引产、II期引产和出生时引产的中位数间隔时间更短(7.3小时vs 10.6小时,14.0小时vs 16.8小时,14.6小时vs 17.6小时);P =0.002, 0.003, 0.002)。口腔组足月产程发生率更高(53.8% vs 15.4%)。此外,口服米索前列醇组在首次给药后6小时内发生足月分娩的可能性是阴道组的3.5倍(OR 3.5, 95% CI 1.33-9.23)。结论:口服米索前列醇用于宫颈成熟已被证明比阴道给药更有效,bishop评分变化更大,同时保持同等水平的安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The difference of Bishop score change and labor event between oral and vaginal misoprostol in pregnancy beyond 41 weeks
HIGHLIGHTS Oral misoprostol is more effective than vaginal misoprostol in cervical ripening as a part of induction of labor. Oral misoprostol is as safe as vaginal misoprostol.   ABSTRACT Objective: To compare Bishop score changes and labor event between oral and vaginal misoprostol in pregnancy beyond 41 weeks. Materials and Methods: A total of 52 pregnant women with more than 41 weeks of gestation, had a Bishop score less than 5, and were undergoing induction labor were randomly divided into two groups: oral and vaginal misoprostol. In the oral misoprostol group, participants were given 25 mg of misoprostol in a solution with a concentration of 1 ug/ml every 2 hours. In the vaginal misoprostol group, a 25 mg misoprostol tablet was inserted into the posterior fornix every 6 hours. The two groups were compared in terms of Bishop score during the first 6 hours, changes in Bishop score, labor at term events, neonatal outcomes, complications, and side effects after the administration of misoprostol. Results: The oral group showed significantly higher changes in Bishop score compared to the vaginal group (5.5 vs 3.6; p=0.0001). The median interval times for induction of labor at term, induction at stage II, and induction at birth were found to be shorter in the oral misoprostol group compared to the vaginal group (7.3 hours vs 10.6 hours, 14.0 hours vs 16.8 hours, and 14.6 hours vs 17.6 hours; p=0.002, 0.003, 0.002). Labor at term occurred much more frequently in the oral group (53.8% vs 15.4%). Additionally, the oral misoprostol group had a 3.5 times higher likelihood of experiencing labor at term within the first 6 hours after the initial administration compared to the vaginal group (OR 3.5, 95% CI 1.33-9.23). Conclusion: Oral administration of misoprostol for cervical ripening has been demonstrated to be more effective than vaginal administration, greater bishop score changes while maintaining an equivalent level of safety.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
16
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信